The panel offers expert perspectives on key factors that inform treatment decisions for patients with HIV.
Video content above is prompted by the following question(s):
1. Three drug regimens have been the mainstay of successful HIV-1 treatment since 1996. Although we have seen improvement in the efficacy, adverse effects, and toxicities of contemporary three-drug regimens, even the newest therapies have potential adverse effects. Two-drug combinations are now part of the treatment guidelines and include the first long-acting antiretroviral regimen for the treatment of HIV-1 suppression. Gibas et al 2022
• Can you discuss two versus three drug regimens? Individualized care
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.